1. Home
  2. SYRE vs CNK Comparison

SYRE vs CNK Comparison

Compare SYRE & CNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$33.30

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Cinemark Holdings Inc Cinemark Holdings Inc.

CNK

Cinemark Holdings Inc Cinemark Holdings Inc.

HOLD

Current Price

$24.02

Market Cap

2.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYRE
CNK
Founded
2013
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.7B
IPO Year
2016
2007

Fundamental Metrics

Financial Performance
Metric
SYRE
CNK
Price
$33.30
$24.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
10
Target Price
$56.50
$34.50
AVG Volume (30 Days)
795.0K
3.1M
Earning Date
02-26-2026
02-18-2026
Dividend Yield
N/A
1.34%
EPS Growth
N/A
N/A
EPS
N/A
1.11
Revenue
N/A
$3,153,000,000.00
Revenue This Year
N/A
$5.95
Revenue Next Year
N/A
$7.68
P/E Ratio
N/A
$21.50
Revenue Growth
N/A
9.70
52 Week Low
$10.91
$21.60
52 Week High
$35.31
$34.01

Technical Indicators

Market Signals
Indicator
SYRE
CNK
Relative Strength Index (RSI) 58.08 51.45
Support Level $30.00 $22.12
Resistance Level $34.21 $23.92
Average True Range (ATR) 1.83 0.96
MACD -0.02 0.31
Stochastic Oscillator 84.46 59.60

Price Performance

Historical Comparison
SYRE
CNK

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.

Share on Social Networks: